title: Antiluteogenic effects of serial prostaglandin F2α administration in cycling mares.
abstract: A single dose of PGF2α does not consistently induce luteolysis in the equine CL until at least 5 days after ovulation, leading to the erroneous assumption that the early CL is refractory to the luteolytic effects of PGF2α. We hypothesized that serial administration of PGF2α in early diestrus would induce a return to estrus similar to mares treated with a single injection in mid-diestrus, and fertility of the induced estrus would not differ. The objectives of the study were to evaluate the effects of the 2 approaches as reflected by: (1) concentrations of plasma progesterone; (2) interovulatory and treatment-to-ovulation intervals; (3) the proportion of mares pregnant after artificial insemination. The study consisted of a balanced crossover design in which 10 reproductively normal Quarter Horse Mares were exposed to 2 treatments on 2 consecutive reproductive cycles. At detected ovulation (Day 0), mares were randomly allotted to 1 of 2 treatment groups: I, mid-diestrus treatment, administration of a single 10-mg dose of dinoprost tromethamine (PGF2α) im on Day 10; II, early diestrus treatment, administration of 10-mg PGF2α im twice daily on Days 0, 1, and 2 and once daily on Days 3 and 4. Mares in estrus and with a follicle 35 mm or greater in diameter were artificially inseminated with at least 2 billion motile sperm from a fertile stallion. Pregnancy was defined as detection of a growing embryonic vesicle on 2 consecutive examinations approximately 14 days after ovulation. Serial plasma samples were collected throughout the study period, and concentration of plasma progesterone was determined by RIA. A mixed-model ANOVA for repeated measures was used to analyze hormonal data. Interovulatory and treatment-to-ovulation intervals were compared by a paired t test and fertility by a McNemar chi-square analysis. All mares in group I underwent luteolysis after PGF2α administration denoted by mean (±SD) concentration of plasma progesterone of 0.25 ± 0.21 ng/mL detected 2 days after treatment. In group II, mean concentration of plasma progesterone remained below 1.0 ng/mL during treatment and until the onset of the next estrus. The mean interovulatory interval in group I was 18.5 ± 2.0 days compared with 13.1 ± 3.7 days in group II (P < 0.01). Treatment-to-ovulation intervals were 8.5 ± 2.0 days and 13.1 ± 3.7 days for groups I and II, respectively (P < 0.05). In both groups, 9 of 10 mares were pregnant (P = 1.0). Serial PGF2α administration beginning at ovulation consistently prevented luteal function in 10 of 10 mares in the present study without adversely affecting pregnancy rate of post-treatment cycles.
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.
authors.forename: E A
authors.initials: EA
authors.lastname: Coffman
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA. Electronic address: cpinto@lsu.edu.
authors.forename: C R F
authors.initials: CR
authors.lastname: Pinto
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.
authors.forename: H K
authors.initials: HK
authors.lastname: Snyder
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Leisinger
authors.affiliation: Department of Animal Sciences, The Ohio State University, Columbus, Ohio, USA.
authors.forename: K
authors.initials: K
authors.lastname: Cole
authors.affiliation: Department of Animal Science, North Carolina State University, Raleigh, North Carolina, USA.
authors.forename: C S
authors.initials: CS
authors.lastname: Whisnant
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D015237:Dinoprost / Q000494:pharmacology*; D004971:Estrus / Q000187:drug effects; D005298:Fertility; D006736:Horses / Q000378:metabolism / Q000502:physiology*; D003341:Luteolysis / Q000187:drug effects*; D008186:Luteolytic Agents / Q000494:pharmacology*
chemical_list: D008186:Luteolytic Agents; D015237:Dinoprost
keywords: Antiluteogenesis; Fertility; Mare; PGF(2α); Progesterone